This explains the risk issues that arise at each stage of the development of a drug or medicinal product by organisations such as:
Pharmaceutical or biotechnology companies.
Providers of healthcare services.
Organisations involved in the development of drugs or medicinal products.
An explanation is given of the types of risk scenarios that can exist or be caused, how they can be controlled or treated and how an insurance solution with supporting risk management services can be created.
Some of the risk management tools that can be used, such as benchmarking of insurance limits, databases of claims or global clinical trials legislation and regulations and risk maps, are referenced as examples of the Marsh Value Proposition for the life science industry.